Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124311) titled 'A real-world study on the treatment of extensive-stage small cell lung cancer with toripalimab combined with chemotherapy at different intervals' on May 10.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Yantai Yuhuangding Hospital

Condition: Extensive-stage small cell lung cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-11

Target Sample Size: Observation group of extensive-stage small cell lung cancer:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=318113

Published by HT Digital ...